Public health. Will vaccines be available for the next influenza pandemic? Science, pp.2195-2196, 2004. ,
Safety and immunogenicity of an inactivated split-virion influenza A/VietnamH5N1) vaccine: phase I randomised trial, Lancet, vol.1194, issue.367, pp.1657-1664, 2004. ,
Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine, New England Journal of Medicine, vol.354, issue.13, pp.1343-1351, 2006. ,
DOI : 10.1056/NEJMoa055778
Strategies for containing an emerging influenza pandemic in Southeast Asia, Nature, vol.7, issue.7056, pp.209-214, 2005. ,
DOI : 10.1002/sim.1912
Containing Pandemic Influenza at the Source, Science, vol.309, issue.5737, pp.1083-1087, 2005. ,
DOI : 10.1126/science.1115717
Strategies for mitigating an influenza pandemic, Nature, vol.304, issue.7101, pp.448-452, 2006. ,
DOI : 10.1038/nature04795
Mitigation strategies for pandemic influenza in the United States, Proceedings of the National Academy of Sciences, vol.432, issue.7019, pp.5935-5940, 2006. ,
DOI : 10.1038/nature03063
Containing Pandemic Influenza with Antiviral Agents, American Journal of Epidemiology, vol.159, issue.7 ,
DOI : 10.1093/aje/kwh092
Volunteer challenge studies, Textbook of Influenza, pp.517-537, 1998. ,
Time lines of infection and disease in human influenza [abstract] V-1698 Volume meta-analyses of randomised controlled trials, 46th Interscience Conference on Antimicrobial Agents and Chemotherapy, pp.27-301235, 2003. ,
Management of Influenza in Households: A Prospective, Randomized Comparison of Oseltamivir Treatment With or Without Postexposure Prophylaxis, The Journal of Infectious Diseases, vol.189, issue.3, pp.440-449, 2004. ,
DOI : 10.1086/381128
Assessment of the Protective Efficacy of Vaccines against Common Diseases Using Case-Control and Cohort Studies, International Journal of Epidemiology, vol.13, issue.1, pp.87-93, 1984. ,
DOI : 10.1093/ije/13.1.87
The Effectiveness of Vaccination against Influenza in Healthy, Working Adults, New England Journal of Medicine, vol.333, issue.14, pp.889-893, 1995. ,
DOI : 10.1056/NEJM199510053331401
Superspreading and the effect of individual variation on disease emergence, Nature, vol.4, issue.7066, pp.355-359, 2005. ,
DOI : 10.1038/nature04153
Properties of highly clustered networks, Physical Review E, vol.68, issue.2, p.26121, 2003. ,
DOI : 10.1103/PhysRevE.68.026121
The role of evolution in the emergence of infectious diseases, Nature, vol.426, issue.6967, pp.658-661, 2003. ,
DOI : 10.1038/nature02104
Limits to Forecasting Precision for Outbreaks of Directly Transmitted Diseases, PLoS Medicine, vol.300, issue.1, p.3, 2006. ,
DOI : 10.1371/journal.pmed.0030003.st001
Resistant influenza A viruses in children treated with oseltamivir: descriptive study, The Lancet, vol.364, issue.9436, pp.759-765, 2004. ,
DOI : 10.1016/S0140-6736(04)16934-1
Avian flu: Isolation of drug-resistant H5N1 virus, Nature, vol.11, issue.7062, p.1108, 2005. ,
DOI : 10.1128/JVI.79.15.9926-9932.2005
Modelling disease outbreaks in realistic urban social networks, Nature, vol.202, issue.6988, pp.180-184, 2004. ,
DOI : 10.1103/PhysRevE.68.026121
Epidemiology: Dimensions of superspreading, Nature, vol.33, issue.7066, pp.293-295, 2005. ,
DOI : 10.1038/438293a
Heterogeneities in the transmission of infectious agents: Implications for the design of control programs, Proceedings of the National Academy of Sciences, vol.20, issue.6306, pp.338-342, 1997. ,
DOI : 10.1038/349243a0
Comparison of Infection Rates and Severity of Illness for Influenza A Subtypes H1N1 and H3N2, Journal of Infectious Diseases, vol.151, issue.1, pp.73-80, 1985. ,
DOI : 10.1093/infdis/151.1.73
Zipf Distribution of U.S. Firm Sizes, Science, vol.293, issue.5536, pp.1818-1820, 2001. ,
DOI : 10.1126/science.1062081